| EPC0297 | A cluster of phylogenetically close strains to the highly virulent variant of HIV-1 subtype B circulating in the Netherlands was detected in Japan | E-poster | Epidemiology of HIV |
| TUPEC09 | A client-centered approach to eliminate mother-to-child transmission of HIV: outcomes from a large ART program in Kisumu County, Kenya | Poster exhibition | Population-specific interventions for HIV prevention |
| EPA0069 | A case of persistent low-level viremia during ART fueled by a clonally expanded provirus with a 3 base deletion in HIV's major splice donor site | E-poster | Understanding and targeting persistent HIV reservoirs |
| TUPEB17 | A biodegradable, subcutaneous implant delivery platform to treat HIV for up to 6 months in young children | Poster exhibition | Other strategies and therapies |
| EPB0222 | A Bayesian update on discontinuation of cabotegravir and rilpivirine using cohort data | E-poster | Antiretroviral therapies and clinical issues in adults |
| EPB0192 | 96-week update: change in weight and BMI associated with switching to bictegravir/emtricitabine/tenofovir alafenamide vs. a dolutegravir-based regimen among virologically suppressed adults living with HIV | E-poster | Clinical complications of HIV and antiretroviral therapy |
| EPB0150 | 24 week efficacy and safety of efavirenz- and dolutegravir-based antiretroviral therapy with isoniazid and rifapentine for tuberculosis preventive therapy (1HP and 3HP) in Thai people living with HIV | E-poster | Co-infections (including opportunistic infections) |
| EPD0600 | Positive Thinking, A Way to Be and Act: use of Facebook to engage young boys aged 15-24 years in HIV prevention, care, and treatment, in four provinces of Mozambique | E-poster | Social and behavioural aspects and approaches to HIV |
| EPA0092 | In vitro modelling to monitor pathogenic implications of viral co-infections | E-poster | HIV-associated viruses, co-infections and co-morbidities |
| MOPEA05 | IL7RA single nucleotide polymorphisms and CMV co-infection associate with MAIT cell dysregulation in treated HIV-1 infection | Poster exhibition | Host immune responses, vaccines and immunotherapies |